+1 650 797 2003 contact@chempartner.com
  • Careers
  • Contact Us
ChemPartner
  • About
    • About ChemPartner
    • CRO Services
    • CDMO Services
    • Awards & Accolades
    • Publications
  • Services
    • Discovery Chemistry
    • Biology & Pharmacology
    • DMPK / Exploratory Toxicology
    • Biologics Discovery
    • Biologics CMC
  • News
    • Latest News
    • Events
    • Webinars
  • Blog
  • Resource Center
Select Page
Genesis of Remdesivir

Genesis of Remdesivir

by Eric Eschmann | Mar 11, 2021 | Uncategorized

Gileadʹs antiviral drug remdesivir (Veklury) was approved by the FDA on May 1, 2020 for emergency use in coronavirus disease-2019 (COVID-19) patients after a one-day review. It took the Japanese government much longer to give the nod, seven days, before granting its...
Next Entries »

Recent Posts

  • Outsourcing Chiral Separations
  • Employee Spotlight: Maria Trance
  • The Year of the Rabbit: Hopping into 2023
  • New Publications Review: Medicinal and Organic Chemistry

Tags

2023 about us ADME antibody B Cell Cloning beacon Biologics Biologics CDMO Biologics CMC Biologics Discovery Biologics Manufacturing CDMO Chemistry Chinese Holidays Chinese Zodiac Chromatography company culture COVID-19 Discovery Biologics DMPK Drug Development Drug Discovery Employee Spotlight Fragment-Based Screening (FBS) General Holidays Hybridoma Lilly Xu Medicinal chemistry Mid-Autumn Festival Neha Yevalakar new research Nobel Prize Operations organic chemistry publications scientist Tox Toxicology Virus
  • Careers
  • Contact Us
©2023 Shanghai ChemPartner, Site by Rhycom